Myelomeningocele in a child with intrauterine exposure to efavirenz.
Fundarò
Carlo
C
Genovese
Orazio
O
Rendeli
Claudia
C
Tamburrini
Enrica
E
Salvaggio
Elio
E
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D048588:Benzoxazines; D003521:Cyclopropanes; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects*; D008591:Meningomyelocele / Q000139:chemically induced* / Q000150:complications; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011297:Prenatal Exposure Delayed Effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D018119:Stavudine; C098320:efavirenz